# EDGAR Filing Document

**Accession Number:** 0001100663
**File Stem:** 0001752724-23-072016
**Filing Date:** 2023-3
**Character Count:** 22993
**Document Hash:** 94d62f2f04d5d86bec7220ef2b117ebe
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-072016.hdr.sgml**: 20230329

**ACCESSION NUMBER**: 0001752724-23-072016

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230131

**FILED AS OF DATE**: 20230329

**DATE AS OF CHANGE**: 20230329

**PERIOD START**: 20230731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** iSHARES TRUST
- **CENTRAL INDEX KEY:** 0001100663
- **IRS NUMBER:** 943351276
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09729
- **FILM NUMBER:** 23774146

**BUSINESS ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105
- **BUSINESS PHONE:** (415) 670-2000

**MAIL ADDRESS:**
- **STREET 1:** 400 HOWARD STREET
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ISHARES TRUST
- **DATE OF NAME CHANGE:** 19991213

## Series and Classes Contracts Data

### iShares Genomics Immunology and Healthcare ETF (Series ID: S000065599)

| Class ID   | Class Name                                     | Ticker Symbol   |
|:---|:---|:---|
| C000212225 | iShares Genomics Immunology and Healthcare ETF | IDNA            |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** iShares Trust

- **b. Investment Company Act file number:** 811-09729

- **c. CIK number of Registrant:** 0001100663

- **d. LEI of Registrant:** 5493000860OXIC4B5K91

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 400 Howard Street

  - **City:** San Francisco

  - **State:** CA

  - **Foreign country:** US

  - **Zip / Postal Code:** 94105

  - **Telephone number:** 800-474-2737

**Item A.2. Information about the Series.**

- **a. Name of Series:** iShares Genomics Immunology and Healthcare ETF

- **b. EDGAR series identifier (if any):** S000065599

- **c. LEI of Series:** 549300KS9JS2Z81CYC21

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-07-31

- **b. Date as of which information is reported:** 2023-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $208317794.08

**Total Liabilities:** $42398046.49

**Net Assets:** $165919747.59

**Cash Not Reported:** $107637.86

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000212225 | 3.62%                | -10.48%              | 6.86%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-481133.37              | $6935924.95                                |
| Month 2  | $-36695317.18            | $17915791.11                               |
| Month 3  | $1990.64                 | $10680176.93                               |

### Schedule of Portfolio Investments

| Name                                           | Title                                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Ligand Pharmaceuticals Inc                     | Ligand Pharmaceuticals Inc                            | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     49320 | NS      | $3437604.00   | 2.07%             |  |  |  | No            |                  1 | On Loan: No      |
| BioNTech SE                                    | BioNTech SE                                           | CUSIP: 09075V102<br>LEI: 894500UZJ5LG1F8J1U58 | Long             | EC               | CORP              | DE        |     41248 | NS      | $5915375.68   | 3.57%             |  |  |  | No            |                  1 | On Loan: No      |
| BioCryst Pharmaceuticals Inc                   | BioCryst Pharmaceuticals Inc                          | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |    547416 | NS      | $5775238.80   | 3.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Caribou Biosciences Inc                        | Caribou Biosciences Inc                               | CUSIP: 142038108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    157483 | NS      | $1135452.43   | 0.68%             |  |  |  | No            |                  1 | On Loan: —       |
| Adicet Bio Inc                                 | Adicet Bio Inc                                        | CUSIP: 007002108<br>LEI: 549300VRD2QO80WBOP18 | Long             | EC               | CORP              | US        |     87411 | NS      | $799810.65    | 0.48%             |  |  |  | No            |                  1 | On Loan: —       |
| Ocugen Inc                                     | Ocugen Inc                                            | CUSIP: 67577C105<br>LEI: 549300JVNUI9CXWJLR09 | Long             | EC               | CORP              | US        |    665558 | NS      | $845258.66    | 0.51%             |  |  |  | No            |                  1 | On Loan: —       |
| BeiGene Ltd                                    | BeiGene Ltd                                           | CUSIP: 000000000<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | KY        |    461800 | NS      | $9076916.80   | 5.47%             |  |  |  | No            |                  2 | On Loan: No      |
| Valneva SE                                     | Valneva SE                                            | CUSIP: 000000000<br>LEI: 969500DIVIP5VKNW4948 | Long             | EC               | CORP              | FR        |    316183 | NS      | $2157720.15   | 1.30%             |  |  |  | No            |                  2 | On Loan: —       |
| OMNIAB INC                                     | OMNIAB INC                                            | CUSIP: 68218J301<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19498 | NS      | $0.19         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Beam Therapeutics Inc                          | Beam Therapeutics Inc                                 | CUSIP: 07373V105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    149540 | NS      | $6497513.00   | 3.92%             |  |  |  | No            |                  1 | On Loan: —       |
| Invitae Corp                                   | Invitae Corp                                          | CUSIP: 46185L103<br>LEI: 549300MYI59DZW1WIX92 | Long             | EC               | CORP              | US        |    735318 | NS      | $1735350.48   | 1.05%             |  |  |  | No            |                  1 | On Loan: —       |
| ABLBio Inc                                     | ABLBio Inc                                            | CUSIP: 000000000<br>LEI: 9884007BRC71Y64NK235 | Long             | EC               | CORP              | KR        |     90029 | NS      | $1440647.90   | 0.87%             |  |  |  | No            |                  2 | On Loan: No      |
| Genmab A/S                                     | Genmab A/S                                            | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |     15172 | NS      | $5945853.05   | 3.58%             |  |  |  | No            |                  2 | On Loan: No      |
| Arcturus Therapeutics Holdings Inc             | Arcturus Therapeutics Holdings Inc                    | CUSIP: 03969T109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     30313 | NS      | $640513.69    | 0.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                      | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |     21376 | NS      | $6672953.86   | 4.02%             |  |  |  | No            |                  2 | On Loan: No      |
| Intellia Therapeutics Inc                      | Intellia Therapeutics Inc                             | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    105158 | NS      | $4462905.52   | 2.69%             |  |  |  | No            |                  1 | On Loan: —       |
| Arbutus Biopharma Corp                         | Arbutus Biopharma Corp                                | CUSIP: 03879J100<br>LEI: 25490064CESONAUIAS23 | Long             | EC               | CORP              | CA        |    423490 | NS      | $1274704.90   | 0.77%             |  |  |  | No            |                  1 | On Loan: No      |
| BlackRock Funds III                            | BlackRock Cash Funds: Institutional, SL Agency Shares | CUSIP: 066922519<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |  21117451 | NS      | $21130121.33  | 12.74%            |  |  |  | No            |                  1 | On Loan: No      |
| Moderna Inc                                    | Moderna Inc                                           | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     38396 | NS      | $6759999.76   | 4.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Iovance Biotherapeutics Inc                    | Iovance Biotherapeutics Inc                           | CUSIP: 462260100<br>LEI: 549300220Z2GHH33XL82 | Long             | EC               | CORP              | US        |    438804 | NS      | $3492879.84   | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Twist Bioscience Corp                          | Twist Bioscience Corp                                 | CUSIP: 90184D100<br>LEI: 549300T23BL59LCOH584 | Long             | EC               | CORP              | US        |    169078 | NS      | $4850847.82   | 2.92%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG                         | CRISPR Therapeutics AG                                | CUSIP: 000000000<br>LEI: 506700O6IRRIQLT3W370 | Long             | EC               | CORP              | CH        |     99746 | NS      | $5089040.92   | 3.07%             |  |  |  | No            |                  1 | On Loan: —       |
| Nkarta Inc                                     | Nkarta Inc                                            | CUSIP: 65487U108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    113410 | NS      | $604475.30    | 0.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Sana Biotechnology Inc                         | Sana Biotechnology Inc                                | CUSIP: 799566104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    108834 | NS      | $496283.04    | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| Inovio Pharmaceuticals Inc                     | Inovio Pharmaceuticals Inc                            | CUSIP: 45773H201<br>LEI: 529900B9W875XDZXTM97 | Long             | EC               | CORP              | US        |    760420 | NS      | $1262297.20   | 0.76%             |  |  |  | No            |                  1 | On Loan: —       |
| ImmunityBio Inc                                | ImmunityBio Inc                                       | CUSIP: 45256X103<br>LEI: 529900J9XLBR4HFL4B83 | Long             | EC               | CORP              | US        |    256433 | NS      | $974445.40    | 0.59%             |  |  |  | No            |                  1 | On Loan: —       |
| Ginkgo Bioworks Holdings Inc                   | Ginkgo Bioworks Holdings Inc                          | CUSIP: 37611X100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   2919382 | NS      | $5692794.90   | 3.43%             |  |  |  | No            |                  1 | On Loan: —       |
| NeoImmuneTech Inc                              | NeoImmuneTech Inc                                     | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |   1361984 | NS      | $4226659.86   | 2.55%             |  |  |  | No            |                  2 | On Loan: No      |
| GeneOne Life Science Inc                       | GeneOne Life Science Inc                              | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | KR        |    221514 | NS      | $1539940.69   | 0.93%             |  |  |  | No            |                  2 | On Loan: No      |
| Medigen Vaccine Biologics Corp                 | Medigen Vaccine Biologics Corp                        | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | TW        |    730815 | NS      | $1791125.85   | 1.08%             |  |  |  | No            |                  2 | On Loan: No      |
| Fate Therapeutics Inc                          | Fate Therapeutics Inc                                 | CUSIP: 31189P102<br>LEI: 549300L14Q4UHOODLA90 | Long             | EC               | CORP              | US        |    282754 | NS      | $1685213.84   | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Atea Pharmaceuticals Inc                       | Atea Pharmaceuticals Inc                              | CUSIP: 04683R106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    225709 | NS      | $1045032.67   | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp                       | Blueprint Medicines Corp                              | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |    143091 | NS      | $6688073.34   | 4.03%             |  |  |  | No            |                  1 | On Loan: —       |
| MacroGenics Inc                                | MacroGenics Inc                                       | CUSIP: 556099109<br>LEI: 5493001KJQUA83L8MH79 | Long             | EC               | CORP              | US        |    182898 | NS      | $1055321.46   | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| MorphoSys AG                                   | MorphoSys AG                                          | CUSIP: 000000000<br>LEI: 529900493806K77LRE72 | Long             | EC               | CORP              | DE        |     45410 | NS      | $912309.25    | 0.55%             |  |  |  | No            |                  2 | On Loan: —       |
| Chicago Mercantile Exchange                    | XAV HEALTH CARE MAR23                                 | CUSIP: 000000000<br>LEI: SNZ2OJLFK8MNNCLQOF39 | N/A              | DE               |  | US        |         2 | NC      | $-13986.54    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Sangamo Therapeutics Inc                       | Sangamo Therapeutics Inc                              | CUSIP: 800677106<br>LEI: 2549006WMRKRC4G32Z67 | Long             | EC               | CORP              | US        |    168049 | NS      | $586491.01    | 0.35%             |  |  |  | No            |                  1 | On Loan: —       |
| Sanofi                                         | Sanofi                                                | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     77940 | NS      | $7632229.65   | 4.60%             |  |  |  | No            |                  2 | On Loan: No      |
| OMNIAB INC                                     | OMNIAB INC                                            | CUSIP: 68218J202<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     19498 | NS      | $0.19         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Adimmune Corp                                  | Adimmune Corp                                         | CUSIP: 000000000<br>LEI: 549300M5TV8YGVXU1827 | Long             | EC               | CORP              | TW        |    948000 | NS      | $1255127.88   | 0.76%             |  |  |  | No            |                  2 | On Loan: No      |
| Prime Medicine Inc                             | Prime Medicine Inc                                    | CUSIP: 74168J101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36585 | NS      | $643164.30    | 0.39%             |  |  |  | No            |                  1 | On Loan: —       |
| Arcus Biosciences Inc                          | Arcus Biosciences Inc                                 | CUSIP: 03969F109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    144333 | NS      | $3121922.79   | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Vir Biotechnology Inc                          | Vir Biotechnology Inc                                 | CUSIP: 92764N102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    247571 | NS      | $7315723.05   | 4.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis Inc                                   | Exelixis Inc                                          | CUSIP: 30161Q104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    402614 | NS      | $7094058.68   | 4.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Editas Medicine Inc                            | Editas Medicine Inc                                   | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               | CORP              | US        |    211156 | NS      | $2088332.84   | 1.26%             |  |  |  | No            |                  1 | On Loan: —       |
| Bionano Genomics Inc                           | Bionano Genomics Inc                                  | CUSIP: 09075F107<br>LEI: 54930086AP7ROH0VJ631 | Long             | EC               | CORP              | US        |    900322 | NS      | $1629582.82   | 0.98%             |  |  |  | No            |                  1 | On Loan: —       |
| Takeda Pharmaceutical Co Ltd                   | Takeda Pharmaceutical Co Ltd                          | CUSIP: 000000000<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |    239100 | NS      | $7516674.68   | 4.53%             |  |  |  | No            |                  2 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                  | Regeneron Pharmaceuticals Inc                         | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      9136 | NS      | $6929381.92   | 4.18%             |  |  |  | No            |                  1 | On Loan: No      |
| CureVac NV                                     | CureVac NV                                            | CUSIP: 000000000<br>LEI: 724500BUT8GAG9LMYN56 | Long             | EC               | CORP              | NL        |    221688 | NS      | $2380929.12   | 1.43%             |  |  |  | No            |                  1 | On Loan: —       |
| Coherus Biosciences Inc                        | Coherus Biosciences Inc                               | CUSIP: 19249H103<br>LEI: 5493007IL8W5MV932D26 | Long             | EC               | CORP              | US        |    225296 | NS      | $1910510.08   | 1.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Karyopharm Therapeutics Inc                    | Karyopharm Therapeutics Inc                           | CUSIP: 48576U106<br>LEI: 549300J1VANRCNTYST87 | Long             | EC               | CORP              | US        |    220712 | NS      | $728349.60    | 0.44%             |  |  |  | No            |                  1 | On Loan: —       |
| SpringWorks Therapeutics Inc                   | SpringWorks Therapeutics Inc                          | CUSIP: 85205L107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    136800 | NS      | $4295520.00   | 2.59%             |  |  |  | No            |                  1 | On Loan: —       |
| Xencor Inc                                     | Xencor Inc                                            | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |     77811 | NS      | $2561538.12   | 1.54%             |  |  |  | No            |                  1 | On Loan: —       |
| BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES | BlackRock Cash Funds: Treasury, SL Agency Shares      | CUSIP: 066922477<br>LEI: 5493008LW2651I1QB503 | Long             | STIV             | RF                | US        |    160000 | NS      | $160000.00    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Allogene Therapeutics Inc                      | Allogene Therapeutics Inc                             | CUSIP: 019770106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    247799 | NS      | $1913008.28   | 1.15%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2023-02-28

**Name of Applicant:** iShares Trust

**Signature:** Chuck Pulsfort

**Name of Signer:** Chuck Pulsfort

**Title:** Assistant Treasurer